touchONCOLOGY joins Dr Markus Joerger (St. Gallen Cancer Center, Switzerland) at ESMO 2021 to discuss the outcome and prognostic factors of COVID-19 infection in cancer patients.
Questions
1. What were the objectives of the SAKK 80/20 study? (00:15-00:50)
2. Could you give us a brief overview of the patient population of this study? (00:50-02:14)
3. What were the findings in terms of outcomes of COVID-19 infection in cancer patients?(02:14-03:57)
4. What conclusions can be made from these findings? (03:57-04:49)
5. What questions remain unanswered and what future studies are needed? (04:49-05:43)
Disclosures: Markus Joerger has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson
Filmed in coverage of the ESMO 2021 Annual Meeting.
